Current:Home > NewsAutoimmune disease patients hit hurdles in diagnosis, costs and care -AdvancementTrade
Autoimmune disease patients hit hurdles in diagnosis, costs and care
View
Date:2025-04-15 15:04:11
After years of debilitating bouts of fatigue, Beth VanOrden finally thought she had an answer to her problems in 2016 when she was diagnosed with Hashimoto's disease, an autoimmune disorder.
For her and millions of other Americans, that's the most common cause of hypothyroidism, a condition in which the thyroid, a butterfly-shaped gland in the neck, doesn't produce enough of the hormones needed for the body to regulate metabolism.
There's no cure for Hashimoto's or hypothyroidism. But VanOrden, who lives in Athens, Texas, started taking levothyroxine, a much-prescribed synthetic thyroid hormone used to treat common symptoms, like fatigue, weight gain, hair loss, and sensitivity to cold.
Most patients do well on levothyroxine and their symptoms resolve. Yet for others, like VanOrden, the drug is not as effective.
For her, that meant floating from doctor to doctor, test to test, and treatment to treatment, spending about $5,000 a year.
"I look and act like a pretty energetic person," says VanOrden, 38, explaining that her symptoms are not visible. "But there is a hole in my gas tank," she says. And "stress makes the hole bigger."
Autoimmune diseases occur when the immune system mistakenly attacks and damages healthy cells and tissues. Other common examples include rheumatoid arthritis, lupus, celiac disease, and inflammatory bowel disease. There are more than 80 such diseases, affecting up to an estimated 50 million Americans, disproportionately women. Overall, the cost of treating autoimmune diseases is estimated at more than $100 billion annually in the U.S.
Despite their frequency, finding help for many autoimmune diseases can prove frustrating and expensive. Getting diagnosed can be a major hurdle because the range of symptoms looks a lot like those of other medical conditions, and there are often no definitive identifying tests, says Dr. Sam Lim, clinical director of the Division of Rheumatology at Emory University School of Medicine in Atlanta. In addition, some patients feel they have to fight to be believed, even by a clinician. And after a diagnosis, many autoimmune patients rack up big bills as they explore treatment options.
"They're often upset. Patients feel dismissed," Dr. Elizabeth McAninch, an endocrinologist and thyroid expert at Stanford University, says of some patients who come to her for help.
Insufficient medical education and lack of investment in new research are two factors that hinder overall understanding of hypothyroidism, according to Antonio Bianco, a University of Chicago endocrinologist and leading expert on the condition.
Some patients become angry when their symptoms don't respond to standard treatments, either levothyroxine or that drug in combination with another hormone, says Douglas Ross, an endocrinologist at Massachusetts General Hospital in Boston. "We will have to remain open to the possibility that we're missing something here," he says.
Jennifer Ryan, 42, says she has spent "thousands of dollars out-of-pocket" looking for answers. Doctors did not recommend thyroid hormone medication for the Huntsville, Alabama, resident — diagnosed with Hashimoto's after years of fatigue and weight gain — because her levels appeared normal. She recently switched doctors and hopes for the best.
"You don't walk around hurting all day long and have nothing wrong," Ryan says.
And health insurers typically deny coverage of novel hypothyroidism treatments, says Brittany Henderson, an endocrinologist and founder of the Charleston Thyroid Center in South Carolina, which sees patients from all 50 states. "Insurance companies want you to use the generics even though many patients don't do well with these treatments," she says.
Meanwhile, the extent of Americans' thyroid problems can be seen in drug sales. Levothyroxine is among the five most prescribed medications in the U.S. every year. Yet research points to some overprescribing of the drug for those with mild hypothyroidism.
A recent study, paid for by AbbVie — maker of Synthroid, a brand-name version of levothyroxine — said a medical and pharmacy claims database showed that the prevalence of hypothyroidism, including milder forms, rose from 9.5% of Americans in 2012 to 11.7% in 2019.
The number of people diagnosed will rise as the population ages, says McAninch. Endocrine disruptors — natural or synthetic chemicals that can affect hormones — could account for some of that increase, she says.
In their search for answers, patients sometimes connect on social media, where they ask questions and describe their thyroid hormone levels, drug regimens, and symptoms. Some online platforms offer information that's dubious at best, but overall, social media outlets have increased patients' understanding of hard-to-resolve symptoms, Bianco says.
They also offer one another encouragement.
VanOrden, who has been active on Reddit, has this advice for other patients: "Don't give up. Continue to advocate for yourself. Somewhere out there is a doctor who will listen to you." She has started an alternative treatment — desiccated thyroid medication, an option not approved by the FDA — plus a low dose of the addiction drug naltrexone, though the data is limited. She's feeling better now.
Research of autoimmune thyroid disease gets little funding, so the underlying causes of immune dysfunction are not well studied, Henderson said. The medical establishment hasn't fully recognized hard-to-treat hypothyroid patients, but increased acknowledgment of them and their symptoms would help fund research, Bianco says.
"I would like a very clear, solid acknowledgment that these patients exist," he says. "These people are real."
KFF Health News, formerly known as Kaiser Health News (KHN), is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.
veryGood! (3248)
Related
- Sonya Massey's father decries possible release of former deputy charged with her death
- Missouri Supreme Court strikes down law against homelessness, COVID vaccine mandates
- If You Don’t Have Time for Holiday Shopping, These Gift Cards Are Great Last-Minute Presents
- How UPS is using A.I. to fight against package thefts
- Tarte Shape Tape Concealer Sells Once Every 4 Seconds: Get 50% Off Before It's Gone
- Paige DeSorbo & Hannah Berner New Year Eve's Fashion Guide to Bring That Main Character Energy in 2024
- Doctors in England begin a 3-day strike over pay at busy time of the year in National Health Service
- Poland’s new government moves to free state media from previous team’s political control
- 'We're reborn!' Gazans express joy at returning home to north
- Xfinity hack affects nearly 36 million customers. Here's what to know.
Ranking
- Israel lets Palestinians go back to northern Gaza for first time in over a year as cease
- Live updates | Talks on Gaza cease-fire and freeing more hostages as Hamas leader is in Egypt
- 23-year-old Miami GOP activist accused joining Proud Boys in Jan. 6 riots
- Orioles prospect Jackson Holliday is USA TODAY Sports' 2023 Minor League Player of the Year
- Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
- Consider this before you hang outdoor Christmas lights: It could make your house a target
- Iran summons Germany’s ambassador over Berlin accusing Tehran in a plot to attack a synagogue
- 93-year-old vet missed Christmas cards. Now he's got more than 600, from strangers nationwide.
Recommendation
Intel's stock did something it hasn't done since 2022
'Thank you for being my friend': The pure joy that was NBA Hall of Famer Dražen Petrović
Barbie’s Greta Gerwig and Noah Baumbach Are Married
A quarter of Methodist congregations abandon the Church as schism grows over LGBTQ issues
Grammy nominee Teddy Swims on love, growth and embracing change
Mega Millions winning numbers for Tuesday: Jackpot rises to $57 million
Sydney Sweeney reveals she bought back the home her mom, grandma were born in
Cinnamon in recalled applesauce pouches may have had 2,000 times the proposed limit of lead